A detailed history of Fmr LLC transactions in Sera Prognostics, Inc. stock. As of the latest transaction made, Fmr LLC holds 14,845 shares of SERA stock, worth $47,355. This represents 0.0% of its overall portfolio holdings.

Number of Shares
14,845
Previous 5,298 180.2%
Holding current value
$47,355
Previous $19,000 115.79%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 14, 2025

BUY
$1.49 - $3.46 $14,225 - $33,032
9,547 Added 180.2%
14,845 $41,000
Q1 2025

May 12, 2025

BUY
$3.54 - $8.33 $11,752 - $27,655
3,320 Added 167.85%
5,298 $19,000
Q4 2024

Feb 13, 2025

BUY
$6.03 - $8.83 $2,617 - $3,832
434 Added 28.11%
1,978 $17,000
Q3 2024

Nov 13, 2024

BUY
$5.29 - $8.43 $8,167 - $13,015
1,544 New
1,544 $12,000
Q2 2022

Aug 12, 2022

BUY
$1.2 - $3.62 $1,718 - $5,183
1,432 Added 1213.56%
1,550 $3,000
Q1 2022

May 13, 2022

BUY
$2.96 - $8.8 $349 - $1,038
118 New
118 $0

Others Institutions Holding SERA

About SERA PROGNOSTICS, INC.


  • Ticker SERA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 29,596,900
  • Market Cap $94.4M
  • Description
  • Sera Prognostics, Inc., a women's health diagnostic company, discovers, develops, and commercializes biomarker tests for improving pregnancy outcomes. The company develops PreTRM test, a blood-based biomarker test to predict the risk of spontaneous preterm birth in asymptomatic singleton pregnancies. It is also developing a portfolio of product ...
More about SERA
Track This Portfolio

Track Fmr LLC Portfolio

Follow Fmr LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fmr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fmr LLC with notifications on news.